ReviewThe Lancet. Global health2025
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications.
Review in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Gender differences in cancer care experiences in Switzerland: a multicentre cross-sectional study.BMJ open · 2026Article
- Urological care for sexual and gender minorities: a narrative review toward equitable care.Current opinion in urology · 2026Review
- Development and validation and risk factor analysis of the colorectal cancer psychosocial distress scale.Scientific reports · 2026Article
- Global determinants of cervical cancer outcomes: a health systems analysis.BMJ oncology · 2026Article
- Multifunctional gold nanoparticles: bridging detection, diagnosis, and targeted therapy in cancer.Molecular cancer · 2025Review
- Oncology Nurses' Attitudes, Knowledge, and Practices in Providing Sexuality Care to Cancer Patients: A Scoping Review.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Little is known about cancer disparities faced by diverse sexual and gender minority (SGM) populations globally, with unique barriers in many low-income and middle-income countries. This Viewpoint examines the intersectional challenges faced by SGM groups across multiple settings in accessing high-quality equitable cancer care. In India, the Hijra population (a legally recognised third gender) experiences compounded discrimination due to stigma and socioeconomic marginalisation. SGM individuals in Kenya and Brazil grapple with interpersonal and institutional discrimination, as well as structural barriers that prevent them from receiving timely cancer treatment. By contrast, Thailand's relative success in engaging communities and implementing inclusive health-care models offers valuable insights into ensuring equitable access to care. Through these global contexts, and cognisant of the diversity of SGM individuals' experiences, we provide multilevel recommendations to increase SGM-inclusive cancer research, foster culturally responsive clinical practices, and advocate for evidence-based policy reforms that decriminalise same-sex relations and promote inclusive health-care access for all SGM populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.